Investigator
Mark W. Jackson
CLEVELAND CLINIC LERNER COM-CWRU · funded by NCI
- Companies
- 1
- Grants
- 5
- Non-dilutive funding
- $1.7M
- First award
- Jun 1, 1993
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 13, 2022.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE36momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- P01
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
$401kSep 13, 2022NCICLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11143072 (opens the source filing in a new tab)
- R01
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
$413kMar 4, 2021NCICASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11036295 (opens the source filing in a new tab)
- R25
Cancer-focused Summer Undergraduate Research (CanSUR) Program
$432kSep 1, 2018NCICASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11064774 (opens the source filing in a new tab)
- P30
Cancer Research Training and Education Coordination
$166kAug 1, 1997NCICASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11089809 (opens the source filing in a new tab)
- T32
Cancer Biology Training Grant
$277kJun 1, 1993NCICASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11121094 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources